These results show that siRNA@PLGA NPs can efficiently suppress the function of P-glycoproteins in the MDR ovarian cancer cells and thus increase the accumulation of intracellular drugs, which is highly associated with potential tumor responsiveness to chemotherapeutics. Here, ABCB1 is linked to neoplasm.